82
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The impact of gamma hydroxybutyrate (GHB) legal restrictions on patterns of use: Results from an International Survey

, , &
Pages 455-469 | Published online: 26 Aug 2010

References

  • Anderson IB, Kim SY, Dyer JE, Burkhardt CB, Iknoian JC, Walsh MJ, et al. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Annals of Emergency Medicine 2006; 47: 177–183
  • Anderson IB, Kim-Katz SY, Dyer JE, Earnest GE, Lamb JP, Blanc PD. Area-level socioeconomic status in relation to outcomes in gamma hydroxybutyrate intoxication. Clinical Toxicology 2008; 11: 1–10
  • Barker JC, Harris SL, Dyer JE. Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study. Journal of Psychoactive Drugs 2007; 39: 115–129
  • Bosman IJ, Lusthof KJ. Forensic cases involving the use of GHB in The Netherlands. Forensic Science International 2003; 133: 17–21
  • Burke BA, Lewis RW, Latenser BA, Chung JY, Willoughby C. Pseudoephedrine legislation decreases methamphetamine laboratory-related burns. Journal of Burn Care & Research 2008; 29: 138–140
  • Caldicott DG, Chow FY, Burns BJ, Felgate PD, Byard RW. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. The Medical Journal of Australia 2004; 181: 310–313
  • CraigsList. Craigslist online community. 2008, Accessed 9 February 2008, from http://www.craigslist.org/about/sites.html
  • Cunningham JK, Liu LM. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 2003; 98: 1229–1237
  • DAWN. The Dawn Report: Club Drugs, 2002 Update. Drug Abuse Warning Network, Substance Abuse & Mental Health Services Administration, US Department of Health and Human Services, Rockville, MD 2004
  • Degenhardt L, Dunn M. The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy, 2008 Aug; 2007; 19(4)311–316
  • Drugs-Forum. Drugs-Forum, International Drugs Community 2008, Accessed, 6 November 2007, from http://www.drugs-forum.com/
  • Duncan DF, White JB, Nicholson T. Using Internet-based surveys to reach hidden populations: Case of nonabusive illicit drug users. American Journal of Health Behavior 2003; 27: 208–218
  • Dyer JE, Anderson I, Kim S, Blanc P, Barker J. Designing a gamma hydroxybutyrate (GHB) structured telephone-administered survey instrument. Journal of Medical Toxicology 2007; 3: 7–14
  • Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine 2001; 37: 147–153
  • ElSohly MA, Salamone SJ. Prevalence of drugs used in cases of alleged sexual assault. Journal of Analytical Toxicology 1999; 23: 141–146
  • EMCDDA. GHB and its precursor GBL: An emerging trend case study. EMCDDA Thematic Papers, European Monitoring Centre for Drugs and Drug Addiction, Lisbon 2008
  • FaceBook. (2007). FaceBook. Accessed January 29, 2007, from http://www.facebook.com/
  • Federal-Register. (2000). Schedules of Controlled Substances: Addition of Gamma-Hydroxybutyric Acid to Schedule I. 21 CFR Part 1301. Retrieved May 27, 2008 from Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr12my00-11] FR Doc 00–11884 65, 30541–30542
  • Gamma A, Jerome L, Liechti ME, Sumnall HR. Is ecstasy perceived to be safe? A critical survey. Drug Alcohol Depend 2005; 77: 185–193
  • Gonzalez A, Nutt DJ. Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology (Oxf) 2005; 19: 195–204
  • Halkitis PN, Palamar JJ. GHB use among gay and bisexual men. Addictive Behaviors 2006; 31: 2135–2139
  • Hovda KE, Bjornaas MA, Skog K, Opdahl A, Drottning P, Ekeberg O, et al. Acute poisonings treated in hospitals in Oslo: A one-year prospective study (I): Pattern of poisoning. Clinical Toxicology (Phila) 2008; 46: 35–41
  • Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: Overview of key findings 2005. NIH publication number D6-5882, 2006, Accessed February 14, 2007, from http://www.monitoringthefuture.org/pubs/monographs/overview2005.pdf
  • Kim SY, Anderson IB, Dyer JE, Barker JC, Blanc PD. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users. The American Journal of Drug and Alcohol Abuse 2007; 33: 429–438
  • Knudsen K, Greter J, Verdicchio M. High mortality rates among GHB abusers in Western Sweden. Clinical Toxicology (Phila) 2008; 46: 187–192
  • Knudsen K, Greter J, Verdicchio M, Cederquist T. GHB, GBL and butanediol poisonings–A serious problem in Western Sweden. Lakartidningen 2005; 102: 3294–3296, 3299
  • Leshner AI. Ecstacy abuse and control: hearing before the Senate Subcommittee on Governmental Affairs 2002
  • Liechti ME, Kunz I, Greminger P, Speich R, Kupferschmidt H. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug and Alcohol Dependency 2006; 81: 323–326
  • McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: Five case studies. Journal of Psychoactive Drugs 2001; 33: 143–149
  • Miller PG, Johnston J, McElwee PR, Noble R. A pilot study using the internet to study patterns of party drug use: Processes, findings and limitations. Drug and Alcohol Review 2007; 26: 169–174
  • MMWR. (1999). Adverse events associated with ingestion of gamma-butyrolactone–Minnesota, New Mexico, and Texas, 1998–1999. Morbidity and Mortality Weekly Report 48, 137–140
  • Palmer RB. Gamma-butyrolactone and 1,4-butanediol: Abused analogues of gamma-hydroxybutyrate. Toxicological Reviews 2004; 23: 21–31
  • Pentney AR. An exploration of the history and controversies surrounding MDMA and MDA. Journal of Psychoactive Drugs 2001; 33: 213–221
  • ProjectGHB. (2008). Project GHB. Accessed May 25, 2008, from http://www.projectghb.org/
  • Reneau J, Nicholson T, White JB, Duncan D. The general well-being of recreational drug users: A survey on the WWW. International Journal of Drug Policy 2000; 11: 315–323
  • Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study. Addictive Behaviors 2004; 29: 743–752
  • Tarabar AF, Nelson LS. The gamma-hydroxybutyrate withdrawal syndrome. Toxicological Reviews 2004; 23: 45–49
  • United States–Canada. (2008). United States–Canada Border Drug Threat Assessment 2007: Precursor Chemicals. p. 16
  • Wikipedia-Contributors. (2008). List of social networking websites. Wikipedia, The Free Encyclopedia
  • Wojtowicz JM, Yarema MC, Wax PM. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: A case report and systematic review. Canadian Journal of Emergency Medical Care 2008; 10: 69–74
  • Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). Monthly Journal of the Association of Physicians 2008; 101: 23–29
  • YouTube. (2007). YouTube. Accessed February 14, 2007, from http://www.youtube.com/results?search_query=dxm&search=Search
  • Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, Peacock EA. Adverse events, including death, associated with the use of 1,4-butanediol. The New England Journal of Medicine 2001; 344: 87–94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.